Washington, April 15 : Researchers at UCLA''s Jonsson Comprehensive Cancer Center say that a non-invasive method can enable cancer specialists to determine after a single cycle of chemotherapy whether the treatment is killing the cancer or not.
The researchers have revealed that they used a combination Positron Emission Tomography (PET) and computed tomography (CT) scanner to monitor 50 patients undergoing treatment for high-grade soft tissue sarcomas.
The patients were receiving neoadjuvant chemotherapy treatments to shrink their tumours prior to surgery, say the researchers.
The study showed that response could be determined about a week after the first dose of chemotherapy drugs.